Publications:

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.

Molecular Oncology

Zhang, Lanxin L; Sun, Siwen S; Zhao, Xiaotian X; Liu, Jingwen J; Xu, Yang Y; Xu, Lingzhi L; Song, Chen C; Li, Na N; Yu, Jing J; Zhao, Shanshan S; Yu, Peiyao P; Fang, Fengqi F; Xie, Jiping J; Ji, Xuening X; Yu, Ruoying R; Ou, Qiuxiang Q; Zhao, Zuowei Z; Li, Man M

Publication Date: 2022-10

Variant appearance in text: EGFR: 2420A>C; D807A

PubMed Link: 35971249

Variant Present in the following documents:

• MOL2-16-3689-s005.xlsx, sheet 1

View BVdb publication page

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth.

Nature Communications

Niu, Mengmeng M; Xu, Jing J; Liu, Yang Y; Li, Yuhuang Y; He, Tao T; Ding, Liangping L; He, Yajun Y; Yi, Yong Y; Li, Fengtian F; Guo, Rongtian R; Gao, Ya Y; Li, Rui R; Li, Luping L; Fu, Mengyuan M; Hu, Qingyong Q; Luo, Yangkun Y; Zhang, Chunyan C; Qin, Kewei K; Yi, Jianqiao J; Yu, Shuhan S; Yang, Jian J; Chen, Hu H; Wang, Liang L; Li, Zhonghan Z; Dong, Biao B; Qi, Shiqian S; Ouyang, Liang L; Zhang, Yujun Y; Cao, Yang Y; Xiao, Zhi-Xiong Jim ZJ

Publication Date: 2021-10-11

Variant appearance in text: EGFR: D807A

PubMed Link: 34635651

Variant Present in the following documents:

• 41467_2021_Article_26222.pdf

View BVdb publication page